Data in Brief (Jun 2020)

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors

  • Helmut Plett, MD,
  • Enzo Ricciardi, MD, PhD,
  • Philipp Harter, MD, PhD,
  • Beyhan Ataseven, MD, PhD,
  • Florian Heitz, MD,
  • Sonia Prader, MD,
  • Stephanie Schneider, MD,
  • Sebastian Heikaus, MD, PhD,
  • Annette Fisseler-Eckhoff, MD, PhD,
  • Friedrich Kommoss, MD, PhD,
  • Sigurd F. Lax, MD, PhD,
  • Annette Staebler, MD, PhD,
  • Alexander Traut,
  • Andreas du Bois, MD, PhD

Journal volume & issue
Vol. 30
p. 105653

Abstract

Read online

The data presented here is related to the research article entitled “FERTILITY-SPARING SURGERY AND REPRODUCTIVE-OUTCOMES IN PATIENTS WITH BORDERLINE OVARIAN TUMORS” by Plett et al. in Journal of Gynecologic Oncology [1] and is analysed and discussed in detail. 18 Patients with Recurrent Borderline Ovarian Tumors (BOT) were identified and listed in Table 1. All patients underwent treatment for primary BOT either per radical surgery (RS) or fertility sparing surgery (FSS) by the same team in Horst Schmidt Klinik (HSK) in Wiesbaden and the Department of Gynecology and Gynecologic Oncology at Kliniken Essen-Mitte between January 2000 and December 2018 and were followed up closely. Details on patients` and surgical characteristics are given as well as management of character of recurrent disease. In Table 2 important publications from the last 20 years are listed in order to visualize better the oncologic outcomes (invasive and non-invasive relapses) and calculated risks of recurrence with the purpose to understand better the important findings of the related article cited above.

Keywords